With insurance costs climbing, many business owners reevaluate their coverage. “These business owners are having to become ...

Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...

While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

When it comes to deciding between building your own AI software solution or purchasing existing software, it’s not about one ...

From cyberthreats to financial volatility, security leaders must grasp the nuances of risk management to build resilient and ...

Pharmaceutical companies in Europe are requesting the EU to adopt drug pricing strategies comparable to the US.

In Nigeria’s corporate environment, the phrase "regulatory compliance" is often brandished as a badge of honour. Annual reports are filed, ...

“It gives you a false view that you understand exactly what's driving all of your business,” she says. “The reality is when ...

While others played safe, Shanghvi bet on complex generics and specialty pharma, and rode a wave of acquisitions to make Sun ...

Amneal Pharmaceuticals, Inc. ( NASDAQ: AMRX) Q1 2025 Earnings Call May 2, 2025 8:30 AM ET Tony DiMeo - Head, Investor Relations Chirag Patel - Co-Founder and Co-Chief Executive Officer Chintu Patel - ...

Bristol-Myers Squibb (BMY) stock is down 11% year-to-date as the company navigates several looming patent cliffs. After a $13 ...